Epicutaneous immunization with hapten-conjugated protein antigen alleviates contact sensitivity mediated by three different types of effector cells

Pharmacological Reports

Volumn 64, Issue 4, 2012, Pages 919-926

  Majewska Szczepanik, Monika ^a   Strzep̧a, Anna ^a   Drozyńska, Iwona ^a   Motyl, Sylwia ^a   Banach, Tomasz ^b   Szczepanik, Marian ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

Author keywords

Contact sensitivity; Hapten; NK cells; Skin induced tolerance; Suppression

Indexed keywords

HAPTEN;

ANIMAL EXPERIMENT; ARTICLE; CONTACT ALLERGY; CONTACT SENSITIVITY; CONTROLLED STUDY; DRUG MECHANISM; EFFECTOR CELL; EPICUTANEOUS IMMUNIZATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATCH TEST; SKIN SENSITIZATION; TH1 CELL;

EID: 84867686239     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70887-3     Document Type: Article

References (27)

1. + NKT cells to initiate contact sensitivity in vivo. J Immunol, 2005, 175, 6390-6401.
2. Askenase PW, Majewska-Szczepanik M, Kerfoot S, Szczepanik M: Participation of iNKT cells in the early and late components of Tc1-mediated DNFB contact sensitivity: Cooperative role of γδ-T cells. Scand J Immunol, 2011, 73, 465-477.
3. + NKT cells and B-1 B cells. Trends Immunol, 2004, 25, 441-449.
4. Bryniarski K, Szczepanik M, Ptak M, Zemelka M, Ptak W: Influence of cyclophosphamide and its metabolic products on the activity of peritoneal macrophages in mice. Pharmacol Rep, 2009, 61, 550-557.
5. Diepgen TL, Weisshaar E: Contact dermatitis: Epidemiology and frequent sensitizers to cosmetics. J Eur Acad Dermatol Venereol, 2007, 21, Suppl 2, 9-13. (Pubitemid 47308235)
6. Herrick CA, MacLeod H, Glusac E, Tigelaar RE, Bottomly K: Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest, 2000, 105, 765-775. (Pubitemid 30164115)
7. Itakura A, Szczepanik M, Campos RA, Paliwal V, Majewska M, Matsuda H, Takatsu K, Askenase PW: An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity. J Immunol, 2005, 175, 7170-7178. (Pubitemid 41713410)
8. Jurynczyk M, Walczak A, Jurewicz A, Jesionek- Kupnicka D, Szczepanik M, Selmaj K: Immune regulation of multiple sclerosis by transdermally applied myelin peptides. Ann Neurol, 2010, 68, 593-601.
9. Kerfoot SM, Szczepanik M, Tung JW, Askenase PW: Identification of initiator B cells, a novel subset of activation-induced deaminase-dependent B-1-like cells that mediate initiation of contact sensitivity. J Immunol, 2008, 181, 1717-1727.
10. Little JR, Eisen HN: Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group. Biochemistry, 1966, 5, 3385-3395.
11. Majewska M, Bryniarski K, Ptak M, Zaja̧c K, Zemelka M, Lobo FM, Ptak W, Szczepanik M: Role of TLR ligands in epicutaneously induced contrasuppression. Pharmacol Rep, 2009, 61, 539-549.
12. Majewska M, Zaja̧c K, Kubera M, Bryniarski K, Ptak M, Basta-Kaim A, Ksia̧żek L et al.: Effect of ovoalbumin on the survival of an H-Y incompatible skin graft in C57BL/6 mice. Pharmacol Rep, 2006, 58, 439-442. (Pubitemid 44111082)
13. Majewska M, Zaja̧c K, Srebro Z, Sura P, Ksia̧żek L, Zemelka M, Szczepanik M: Epicutaneous immunization with myelin basic protein protects from the experimental autoimmune encephalomyelitis. Pharmacol Rep, 2007, 59, 74-79. (Pubitemid 46522705)
14. Marra F, Marra CA, Richardson K, Lynd LD, Fitzgerald MJ: Antibiotic consumption in children prior to diagnosis of asthma. BMC Pulm Med, 2011, 11, 32.
15. McKinneyMM, ParkinsonA:Asimple, non-chromatographic procedure to purify immunoglobulins fromserumand ascites fluid. J ImmunolMethods, 1987, 96, 271-278.
16. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH: T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol, 2006, 7, 507-516.
17. Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, Szczepanik M et al.: Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigenspecific memory of haptens and viruses. Nat Immunol, 2010, 11, 1127-1135.
18. + T contrasuppressor cells that reverse skin-induced suppression of Th1-mediated contact sensitivity. J Immunol, 2009, 182, 837-850.
19. Ptak W, Szczepanik M, Bryniarski K, Tutaj M, Ptak M: Epicutaneous application of protein antigens incorporated into cosmetic cream induces antigen-nonspecific unresponsiveness in mice and affects the cell-mediated immune response. Int Arch Allergy Immunol, 2002, 128, 8-14. (Pubitemid 34621661)
20. Strzȩpa A, Szczepanik M: IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders. Pharmacol Rep, 2011, 63, 30-44.
21. Szczepanik M, Anderson LR, Ushio H, Ptak W, Owen MJ, Hayday AC, Askenase PW: γδ T cells from tolerized αβ T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their interferon-γ production in vitro. J Exp Med, 1996, 184, 2129-2139.
22. Szczepanik M, Bryniarski K, Tutaj M, Ptak M, Skrzeczynska J, Askenase PW, Ptak W: Epicutaneous immunization induces αβ T-cell receptor CD4 CD8 doublepositive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta. Immunology, 2005, 115, 42-54. (Pubitemid 40593290)
23. Szczepanik M, Tutaj M, Bryniarski K, Dittel BN: Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis. J Neuroimmunol, 2005, 164, 105-114. (Pubitemid 40826767)
24. + double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE). J Autoimmun, 2007, 28, 208-215.
25. van Beelen AJ, Teunissen MB, Kapsenberg ML, de Jong EC: Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol, 2007, 7, 374-381. (Pubitemid 47415279)
26. Wang LF, Lin JY, Hsieh KH, Lin RH: Epicutaneous exposure of protein antigen induces a predominant Th2- like response with high IgE production in mice. J Immunol, 1996, 156, 4077-4082.
27. Weiner HL, da Cunha AP, Quintana F, Wu H: Oral tolerance. Immunol Rev, 2011, 241, 241-259.